Related Experiment Video

Updated: May 10, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

[Anticonvulsant effect of dicholine succinate on primary generalized epilepsy model in mice]

V M Rychikhin, A K Sariev, I A Pomytkin

    Eksperimental'Naia I Klinicheskaia Farmakologiia
    |June 18, 2013
    PubMed

    Insights

    Dicholine succinate (DCS), a neuronal insulin sensitizer, shows anticonvulsant effects in a mouse model of corazole-induced epilepsy. However, DCS did not demonstrate efficacy against maximal electroshock-induced seizures in the study.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Epilepsy Research

    Background:

    • Epilepsy is a neurological disorder characterized by recurrent seizures.
    • Developing novel anticonvulsant therapies remains a critical area of research.
    • Neuronal insulin sensitizers are being explored for their potential therapeutic effects.

    Purpose of the Study:

    • To investigate the anticonvulsant properties of dicholine succinate (DCS).
    • To evaluate DCS efficacy in two distinct models of primary generalized epilepsy.
    • To assess the impact of DCS on seizure latency, seizure characteristics, and survival rates.

    Main Methods:

    • The study utilized two established epilepsy models in mice: corazole-induced seizures and maximal electroshock (ME)-induced seizures.
    • Dicholine succinate (DCS) was administered intraperitoneally at a dose of 10 mg/kg for seven consecutive days.
    • Anticonvulsant effects were assessed by measuring seizure latency, seizure severity, and animal survival.

    Main Results:

    • Dicholine succinate (DCS) demonstrated a significant anticonvulsant effect in the corazole-induced seizure model.
    • DCS increased seizure latency and altered seizure characteristics in corazole-treated mice, improving survival.
    • No significant anticonvulsant effect of DCS was observed in the maximal electroshock (ME)-induced seizure model.

    Conclusions:

    • Dicholine succinate (DCS) exhibits specific anticonvulsant activity against corazole-induced seizures in mice.
    • The findings suggest DCS may have potential as a therapeutic agent for certain types of epilepsy.
    • Further research is warranted to elucidate the mechanisms of action and therapeutic potential of DCS in epilepsy.

    More Related Videos

    Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy09:29

    Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy

    Published on: August 17, 2021

    A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus05:33

    A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

    Published on: June 23, 2022

    Related Concept Videos

    Depolarizing Blockers: Pharmocokinetics01:19

    Depolarizing Blockers: Pharmocokinetics

    Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
    Epilepsy and Seizures: Overview01:24

    Epilepsy and Seizures: Overview

    Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
    Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
    Antiepileptic Drugs: Glutamate Antagonists01:14

    Antiepileptic Drugs: Glutamate Antagonists

    Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
    Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

    Antiepileptic Drugs: GABAergic Pathway Potentiators

    γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
    The key GABA pathway potentiators used in epilepsy management are as follows.
    Benzodiazepines are a well-known class of drugs used for their...
    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...